LYXOFLAVINE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C17H20N4O6
Molecular Weight	376.3639
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2

InChI

InChIKey=AUNGANRZJHBGPY-OBJOEFQTSA-N

InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12-,14-/m0/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18127592

Lyxose, an analog of riboflavin, isolated from human myocardium.

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2578

PubMed

Title	Date	PubMed

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Name

Type

Language

LYXOFLAVINE

Common Name

English

NSC-18343

Code

English

L-ARABINITOL, 5-DEOXY-5-(3,4-DIHYDRO-7,8-DIMETHYL-2,4-DIOXOBENZO(G)PTERIDIN-10(2H)-YL)-

Systematic Name

English

LYXOFLAVINE [MI]

Common Name

English

Code System Code Type Description

NSC

18343